Dimensional Fund Advisors
SNDX icon

Dimensional Fund Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Dimensional Fund Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,312
Closed -$595K – 3291
2025
Q4 		$595K Sell
28,312
-93,155
-77% -$1.63M ﹤0.01% 2941
2025
Q3 		$1.87M Sell
121,467
-366,180
-75% -$4.79M ﹤0.01% 2778
2025
Q2 		$4.57M Buy
487,647
+21,765
+5% +$240K ﹤0.01% 2548
2025
Q1 		$5.72M Buy
465,882
+134,582
+41% +$1.9M ﹤0.01% 2460
2024
Q4 		$4.38M Buy
331,300
+283,577
+594% +$4.85M ﹤0.01% 2576
2024
Q3 		$919K Sell
47,723
-22,458
-32% -$464K ﹤0.01% 2926
2024
Q2 		$1.44M Sell
70,181
-38,464
-35% -$805K ﹤0.01% 2843
2024
Q1 		$2.59M Sell
108,645
-658
-0.6% -$14.7K ﹤0.01% 2733
2023
Q4 		$2.36M Buy
109,303
+3,163
+3% +$48.6K ﹤0.01% 2758
2023
Q3 		$1.54M Sell
106,140
-488,322
-82% -$9.24M ﹤0.01% 2839
2023
Q2 		$12.4M Sell
594,462
-725,763
-55% -$15.1M ﹤0.01% 2159
2023
Q1 		$27.9M Buy
1,320,225
+54,096
+4% +$1.35M 0.01% 1734
2022
Q4 		$32.2K Buy
1,266,129
+143,677
+13% +$3.35M 0.01% 1606
2022
Q3 		$27M Buy
1,122,452
+161,346
+17% +$3.62M 0.01% 1651
2022
Q2 		$18.5M Buy
961,106
+76,772
+9% +$1.28M 0.01% 1907
2022
Q1 		$15.4M Buy
884,334
+90,634
+11% +$1.53M ﹤0.01% 2110
2021
Q4 		$17.4M Buy
793,700
+145,674
+22% +$2.69M 0.01% 2061
2021
Q3 		$12.4M Buy
648,026
+146,228
+29% +$2.44M ﹤0.01% 2230
2021
Q2 		$8.62M Sell
501,798
-207,841
-29% -$3.81M ﹤0.01% 2432
2021
Q1 		$15.8M Sell
709,639
-66,069
-9% -$1.49M 0.01% 2117
2020
Q4 		$17.3M Sell
775,708
-78,260
-9% -$1.62M 0.01% 2050
2020
Q3 		$12.6M Sell
853,968
-29,268
-3% -$446K 0.01% 2085
2020
Q2 		$13.1M Sell
883,236
-5,280
-0.6% -$80.4K 0.01% 2092
2020
Q1 		$9.75M Sell
888,516
-49,445
-5% -$464K 0.01% 2133
2019
Q4 		$8.23M Sell
937,961
-18,979
-2% -$139K ﹤0.01% 2426
2019
Q3 		$7.15M Buy
956,940
+12,490
+1% +$114K ﹤0.01% 2476
2019
Q2 		$8.79M Buy
944,450
+36,597
+4% +$267K ﹤0.01% 2440
2019
Q1 		$4.77M Buy
907,853
+97,669
+12% +$557K ﹤0.01% 2664
2018
Q4 		$3.6M Buy
810,184
+14,417
+2% +$79K ﹤0.01% 2701
2018
Q3 		$6.43M Buy
795,767
+237,042
+42% +$1.69M ﹤0.01% 2607
2018
Q2 		$3.92M Buy
558,725
+161,146
+41% +$1.58M ﹤0.01% 2726
2018
Q1 		$5.66M Buy
397,579
+173,821
+78% +$1.84M ﹤0.01% 2590
2017
Q4 		$1.96M Buy
223,758
+168,478
+305% +$1.67M ﹤0.01% 2860
2017
Q3 		$647K Buy
55,280
+41,537
+302% +$509K ﹤0.01% 3070
2017
Q2 		$192K Buy
+13,743
New +$157K ﹤0.01% 3203

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Dimensional Fund Advisors's SNDX Position: Q1 2026 in Review

Dimensional Fund Advisors sold out of Syndax Pharmaceuticals (SNDX) in Q1 2026, closing a stake of 28,312 shares — an estimated $595K sold.

Dimensional Fund Advisors first reported a position in SNDX in Q2 2017 and held it in 35 quarters. The position peaked at $27.9M in Q1 2023. 247 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Dimensional Fund Advisors reported no remaining Syndax Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 28,312 Syndax Pharmaceuticals shares in Q1 2026, an estimated $595K.
  • Dimensional Fund Advisors first reported a position in Syndax Pharmaceuticals in Q2 2017 and held it in 35 quarters.
  • Dimensional Fund Advisors's Syndax Pharmaceuticals position peaked at $27.9M in Q1 2023.
  • 247 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.